Загрузка...

Once-monthly risedronate for postmenopausal osteoporosis

Bisphosphonates are the mainstay of treatment for postmenopausal women with osteoporosis. Despite numerous clinical trials documenting efficacy, tolerability, and safety of bisphosphonate therapy, long-term persistence and adherence to these agents remains low. This has serious consequences for pati...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Casadei, Kristina, Becker, Carolyn
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2010
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2971711/
https://ncbi.nlm.nih.gov/pubmed/21072270
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!